drugset / Trial / NCT02621060

Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance

NCT02621060

Phase 2 Completed 30 enrolled University of Guadalajara
RandomizedParallel-groupTriple-blindTreatment

Summary

Chlorogenic acid has demonstrated promising effects in the treatment of glycemic control, obesity, dyslipidemia, insulin secretion, among others. The above mentioned findings show that Chlorogenic acid has an excellent potential for the control of glucose as well as insulin secretion and insulin sensitivity.

Timeline

Start
2015-09
Primary completion
2016-01
Completion
2016-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorogenic acid Small molecule 400 mg

Indications